Omnicell, Inc. (OMCL)
NASDAQ: OMCL · IEX Real-Time Price · USD
27.83
+0.58 (2.13%)
At close: Apr 19, 2024, 4:00 PM
28.09
+0.26 (0.93%)
After-hours: Apr 19, 2024, 7:53 PM EDT
Omnicell Market Cap
Omnicell has a market cap or net worth of $1.28 billion as of April 19, 2024. Its market cap has decreased by -52.97% in one year.
Market Cap
1.28B
Enterprise Value
1.41B
1-Year Change
-52.97%
Ranking
Category
Stock Price
$27.83
Market Cap Chart
Since August 9, 2001, Omnicell's market cap has increased from $181.10M to $1.28B, an increase of 605.59%. That is a compound annual growth rate of 8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 1.25B | 3.73% |
| Apr 17, 2024 | 1.21B | -1.42% |
| Apr 16, 2024 | 1.22B | -0.86% |
| Apr 15, 2024 | 1.23B | -1.11% |
| Apr 12, 2024 | 1.25B | -0.51% |
| Apr 11, 2024 | 1.25B | -0.44% |
| Apr 10, 2024 | 1.26B | -4.19% |
| Apr 9, 2024 | 1.32B | 2.65% |
| Apr 8, 2024 | 1.28B | 1.38% |
| Apr 5, 2024 | 1.26B | -0.25% |
| Apr 4, 2024 | 1.27B | 0.07% |
| Apr 3, 2024 | 1.27B | -0.64% |
| Apr 2, 2024 | 1.27B | -3.08% |
| Apr 1, 2024 | 1.31B | -2.05% |
| Mar 28, 2024 | 1.34B | -0.04% |
| Mar 27, 2024 | 1.34B | 4.84% |
| Mar 26, 2024 | 1.28B | -1.79% |
| Mar 25, 2024 | 1.30B | 1.68% |
| Mar 22, 2024 | 1.28B | -1.79% |
| Mar 21, 2024 | 1.31B | 1.82% |
| Mar 20, 2024 | 1.28B | 1.05% |
| Mar 19, 2024 | 1.27B | 0.62% |
| Mar 18, 2024 | 1.26B | -0.79% |
| Mar 15, 2024 | 1.27B | 0.36% |
| Mar 14, 2024 | 1.27B | -0.61% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdaptHealth | 1.29B |
| Pacira BioSciences | 1.24B |
| Spyre Therapeutics | 1.24B |
| Soleno Therapeutics | 1.23B |
| Brookdale Senior Living | 1.22B |
| Ironwood Pharmaceuticals | 1.20B |
| Kiniksa Pharmaceuticals | 1.20B |
| Deciphera Pharmaceuticals | 1.19B |